Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18501a21b1159369fa25d8fac6c00fb0 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea548f8ca197e423cb0f076e45f84a66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760a7d727d8b57ab2b84421019baf38d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06de374354c5a7aeee49a9e99f0cd8dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3029bd09689e613a473abfd598dd81f2 |
publicationDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2012245287-B2 |
titleOfInvention |
Compounds for the treatment of neuropsychiatric disorders |
abstract |
Described herein are compositions which include digestive enzymes and which are formulated to reduce one or more symptoms of a neuropsychiatric disorder. Also described herein is a method for treating an individual with a neuropsychiatric disorder using digestive enzymes and their derivatives to alleviate the symptoms of neuropsychiatric disorders. The method comprises administering to the individual an effective amount of digestive enzymes that are either naturally or recombinantly derived, or their derivatives, in an amount effective to reduce one or more symptoms of the neuropsychiatric disorder. |
priorityDate |
2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |